INJE UNIVERSITY EXCELLENT TECHNOLOGY SOURCE BOOK INJE LINC INFACO INTELLECTUAL PROPERTY INJE UNIVERSITY FAMILY COMPANY EXPERIMENT RESEARCH
INTELLECTUAL PROPERTY INFACO INJE LINC EXPERIMENT INJE UNIVERSITY FAMILY COMPANY INJE UNIVERSITY EXCELLENT TECHNOLOGY SOURCE BOOK RESEARCH
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16 5 6 6 7 7 7 10 12 14 16 18 20 22 24 4 26 28 30 32 34 36 38 40
4
01 02 03 04 05 01 02 03 04 05 06 5
6
7
8
INJE UNIVERSITY EXCELLENT TECHNOLOGY SOURCE BOOK 9
01 10
100 80 60 40 20 0 LS174T/H9/IacZ P < 0.0005(n=10) MDA-MB435/H9/IacZ Global Spending US$Bn 100 80 60 40 20 0 $48Bn 7% 14% 6% 5% 6% $65Bn 7-10% 11-14% 7-10% 7-10% 7-10% $85-115Bn 2008 2013 2018 US EU Japan Pharmerging ROW CAGR 2009-2013 6% CAGR 2014-2018 7-10% 11
02 12
80 CAGR:17.7% 70 60 50 40 30 20 10 0 2011 2012 2013 2014 2015 36 42 50 59 69 6,000 CAGR:37.1% 5,000 4,000 3,000 2,000 1,000 0 2011 2012 2013 2014 2015 1,478 1,922 2,652 3,715 5,220 13
03 14
15
04 16
989.9 1437.7 2088.0 323.1 469.3 681.6 2010 2011 2012 2013 2014 2015 17
05 18
70 60 50 40 30 20 10 8% 7% 6% 5% 4% 3% 2% 1% 0 2009 2010 2011 2012 2013 2014 2015 2016 2017 0% 19
06 20
1000 800 600 400 200 6000 5000 4000 3000 2000 1000 0 0 10 10 10 10 0 0 5 10 50 0 0 10 10 10 10 0 0 5 10 50 2500 2000 1500 1000 160 120 80 500 40 0 0 10 10 10 10 0 0 5 10 50 0 0 10 10 10 10 0 0 5 10 50 700,000 550,000 420,000 280,000 583,372 525,614 400,236 441,198 627,325 140,000 0 2009 2010 2011 2012 2013 21
07 22
900,000 800,000 700,000-15 -14 600,000 500,000-13 400,000 300,000 572,550 638,088 688,313 715,047 732,982 751,004-12 200,000-11 100,000-41,847 50,169 55,653 58,267 56,726 56,133 2008 2009 2010 2011 2012 2013-10 23
08 24
7.00 6.00 6.00 5.00 F old Change 5.00 4.00 3.00 2.00 F old Change 4.00 3.00 2.00 1.00 1.00 0.00 1 2 0.00 1 2 70,000.00 60,000.00 50,000.00 40,000.00 30,000.00 20,000.00 10,000.00 0.00 Immunomodulating Symptom-relieving Immunosuppressants 2000 2005 2007 2010 25
09 26
50 40 8,430,492 10,279,249 12,899,694 30 20 10 2012 2013 2014 0 2007 2008 2009 2010 2011 2012 2013 2014 27
10 28
29
11 30
1,400 1,300 1,200 1,100 1,000 140 131 1,323 120 100 80 109 1,135 60 40 20 0 2007 2011 2007 2011 31
12 32
33
13 34
50000 45000 40000 35000 30000 25000 20000 15000 10000 5000 0 44581 41860 39305 36899 34640 32384 2012 2013 2014 2015 2016 2017 900 800 700 600 500 400 300 200 100 0 777 695 621 555 497 444 2012 2013 2014 2015 2016 2017 35
14 36
37
15 38
5.0 4.5 4.0 3.5 3.0 2.5 2.0 0 5 20 50 352.7 284.9 221.1 121.6 157.3 55.5 2015 2016 2017 2018 2019 2020 39
16 40
200.00 160.00 120.00 30.00 10.00 0.00 10/8 10/28 11/17 12/7 12/27 1/16 2/5 350 300 250 200 150 100 50 0 10/19 11/8 11/28 12/18 1/7 1/27 2/16 80.000 70.000 Wastewater Water 60.000 $ Million 50.000 40.000 30.000 20.000 10.000 0 2011 2012 2013 2014 2015 2016 2017 2018 Capex($ million) 2011 2012 2013 2014 2015 2016 2017 2018 Water 42,725.8 45,333.6 47,296.3 49,000.4 52,112.9 55,992.0 59,560.8 63,654.2 Wastewater 53,871.0 57,615.8 59,384.9 61,895.8 63,994.9 68,328.6 73,186.9 78,629.9 Total 96,596.9 102,949.3 106,681.2 110,896.2 116,117.8 124,320.6 132,747.7 142,284.1 41
INJE UNIVERSITY EXCELLENT TECHNOLOGY SOURCE BOOK